Orbis Allan Gray LTD Abb Vie Inc. Transaction History

Orbis Allan Gray LTD

$15.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $47.8 Million - $60.7 Million	-347,007 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $18.1 Million - $22.5 Million	-137,297 Reduced 28.35%	347,007 $56.3 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $271 Million - $343 Million	-2,522,350 Reduced 83.89%	484,304 $65.6 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $386 Million - $438 Million	-3,625,731 Reduced 54.67%	3,006,654 $324 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $19.4 Million - $21.6 Million	-184,398 Reduced 2.71%	6,632,385 $747 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $140 Million - $154 Million	-1,368,003 Reduced 16.71%	6,816,783 $738 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $87.4 Million - $118 Million	-1,086,401 Reduced 11.72%	8,184,786 $877 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $109 Million - $128 Million	-1,272,552 Reduced 12.07%	9,271,187 $812 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $220 Million - $294 Million	-2,996,311 Reduced 22.13%	10,543,739 $1.04 Billion
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $165 Million - $250 Million	-2,558,246 Reduced 15.89%	13,540,050 $1.03 Billion
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $81.2 Million - $102 Million	-1,126,356 Reduced 6.54%	16,098,296 $1.43 Billion
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $3.56 Million - $4.28 Million	56,499 Added 0.33%	17,224,652 $1.3 Billion
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $42.2 Million - $53.9 Million	-642,029 Reduced 3.6%	17,168,153 $1.25 Billion
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $92.8 Million - $109 Million	1,203,644 Added 7.25%	17,810,182 $1.44 Billion
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $74.1 Million - $91.4 Million	952,014 Added 6.08%	16,606,538 $1.53 Billion
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $85.8 Million - $95.4 Million	965,272 Added 6.57%	15,654,524 $1.48 Billion
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $108 Million - $128 Million	1,203,008 Added 8.92%	14,689,252 $1.36 Billion
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $77.8 Million - $104 Million	845,276 Added 6.69%	13,486,244 $1.28 Billion
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $50.4 Million - $55.3 Million	-562,956 Reduced 4.26%	12,640,968 $1.22 Billion
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $922 Million - $1.18 Billion	13,203,924	13,203,924 $1.17 Billion

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

News

Stay updated on Orbis Allan Gray LTD with notifications on news.

Account